Comprehensive Healthcare Systems Inc (TSE:CHS)
:CHS
Want to see TSE:CHS full AI Analyst Report?
Top Page
Comprehensive Healthcare Systems Inc
(CHS)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.57
▼(-1.21% Downside)
Action:Reiterated
Date:05/29/26
The score is held down primarily by weak financial fundamentals (ongoing losses, negative cash flow, and negative equity). Technicals also remain soft with the stock trading below major moving averages and a negative MACD, while valuation offers limited support given the negative P/E and no dividend yield data.
Positive Factors
Revenue Growth
Sustained TTM revenue acceleration indicates growing customer adoption and traction in healthcare information services. Durable top-line growth improves potential scale economics and provides a runway to leverage fixed costs into future operating leverage if management controls SG&A.
Negative Factors
Persistent Losses
Consistent net and operating losses show the business still fails to convert revenue into sustainable profits. Over a multi-month horizon this necessitates funding, constrains reinvestment capacity, and increases execution risk before durable profitability is achieved.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained TTM revenue acceleration indicates growing customer adoption and traction in healthcare information services. Durable top-line growth improves potential scale economics and provides a runway to leverage fixed costs into future operating leverage if management controls SG&A.
Read all positive factors
Comprehensive Healthcare Systems Inc (CHS) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$10.59M
Dividend YieldN/A
Average Volume (3M)12.96K
Price to Earnings (P/E)―
Beta (1Y)0.04
Revenue Growth9.06%
EPS Growth-42.75%
CountryCA
Employees47
SectorGeneral
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.13
Shares Outstanding17,948,120
10 Day Avg. Volume12,600
30 Day Avg. Volume12,958
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)-0.95
Price to Sales (P/S)1.40
P/FCF Ratio-6.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Comprehensive Healthcare Systems Inc Business Overview & Revenue Model
Company Description
Comprehensive Healthcare Systems Inc. develops customized healthcare administrative software solutions. It offers membership cards, disease management, pre-certification, claim processing, and bill payment services. The company also provides licen...
Comprehensive Healthcare Systems Inc Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
14
Very Negative
Cash Flow
22
Negative
| Breakdown | Mar 2026 | Mar 2025 | Sep 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.19M | 3.77M | 3.84M | 4.30M | 4.50M |
| Gross Profit | 2.37M | 2.06M | 1.15M | 1.40M | 1.37M |
| EBITDA | -1.10M | 121.99K | -2.86M | -5.13M | -2.63M |
| Net Income | -2.18M | -607.73K | -3.58M | -5.11M | -4.93M |
Balance Sheet | |||||
| Total Assets | 925.61K | 938.55K | 1.28M | 2.11M | 4.11M |
| Cash, Cash Equivalents and Short-Term Investments | 39.88K | 11.03K | 31.55K | 542.64K | 3.40M |
| Total Debt | 2.67M | 3.59M | 3.28M | 1.96M | 2.22M |
| Total Liabilities | 7.13M | 10.19M | 9.01M | 5.26M | 3.50M |
| Stockholders Equity | -6.20M | -9.25M | -7.73M | -3.15M | 602.59K |
Cash Flow | |||||
| Free Cash Flow | -900.62K | 36.31K | -1.23M | -4.04M | -3.28M |
| Operating Cash Flow | -723.57K | 366.80K | -1.23M | -3.97M | -3.27M |
| Investing Cash Flow | -97.80K | -628.01K | 0.00 | -68.41K | 215.14K |
| Financing Cash Flow | 854.22K | 245.07K | 852.45K | 1.04M | 4.39M |
Comprehensive Healthcare Systems Inc Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | C$463.01M | 63.11 | 2.98% | ― | 58.90% | 124.86% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
48 Neutral | C$59.75M | -5.48 | -207.53% | ― | 15725.47% | -26.12% | |
45 Neutral | C$26.49M | -5.74 | 3086.87% | ― | -46.50% | 1.32% | |
42 Neutral | C$8.20M | -2.81 | 6239.15% | ― | ― | 68.00% | |
41 Neutral | C$10.59M | -3.49 | ― | ― | 9.06% | -42.75% | |
| ― | C$6.28M | -4.62 | 527.45% | ― | ― | -61.90% |
* General Sector Average
TSE:CHS
Comprehensive Healthcare Systems Inc
0.60
0.39
185.71%
TSE:ADK
Diagnos
0.23
0.01
4.55%
TSE:VHI
Vitalhub
7.29
-2.82
-27.89%
TSE:AIDR
Rocket Doctor AI
0.64
0.25
64.10%
TSE:UDOC
UniDoc Health Corp
0.11
-0.15
-58.00%
TSE:DMED
DiagnaMed Holdings Corp.
0.06
0.02
57.14%
Comprehensive Healthcare Systems Inc Corporate Events
Business Operations and StrategyExecutive/Board Changes
Comprehensive Healthcare Systems Taps Veteran Executive to Lead Sales Push
Positive
Apr 16, 2026
Comprehensive Healthcare Systems Inc. has appointed veteran healthcare technology executive John C. Seguin as Vice President of Sales, tasking him with leading the sales organization and expanding the commercial pipeline for its Novus 360 benefits...
Business Operations and StrategyPrivate Placements and Financing
Comprehensive Healthcare Systems Raises $5.6 Million in Completed Private Placement
Positive
Apr 14, 2026
Comprehensive Healthcare Systems Inc. has closed the second and final tranche of its non-brokered private placement, issuing 4,038,462 units at $0.52 each for gross proceeds of $2.1 million, with each unit consisting of one share and a half-warran...
Business Operations and StrategyFinancial Disclosures
Comprehensive Healthcare Systems CEO Signals Shift From Restructuring to Growth
Positive
Apr 13, 2026
Comprehensive Healthcare Systems’ CEO outlined the company’s transition from restructuring to growth, anchored by its Novus 360 SaaS platform, which now supports over one million members and underpins a highly recurring revenue base wi...
Business Operations and Strategy
Comprehensive Healthcare Systems Expands US$20 Million Pipeline and Upgrades Commercial Infrastructure
Positive
Mar 31, 2026
Comprehensive Healthcare Systems Inc. reported that its active sales pipeline has grown to more than US$20 million, driven by heightened engagement with U.S. labor unions, third-party administrators and self-insured employers. Management attribute...
Business Operations and StrategyProduct-Related Announcements
Comprehensive Healthcare Systems Launches AI Initiative to Advance Novus 360 Platform
Positive
Mar 18, 2026
Comprehensive Healthcare Systems Inc. has launched a new artificial intelligence initiative to embed advanced analytics and intelligent automation across its Novus 360 platform and broader benefits administration offering. The move aims to improve...
Business Operations and StrategyPrivate Placements and Financing
Comprehensive Healthcare Systems Extends Second Tranche of Private Placement
Positive
Mar 14, 2026
Comprehensive Healthcare Systems Inc. has extended by 30 days the second tranche of its non-brokered private placement, allowing additional subscriptions for up to 4,038,462 units at $0.52 each for potential proceeds of about $2.1 million. The ext...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.